← All companies

CDT — CDT Equity Inc.

Materials · Pharmaceutical Preparations · Nasdaq

CIK 0001896212 · FYE 1231 · All Form 4 filings on EDGAR ↗

Formerly: CONDUIT PHARMACEUTICALS INC. (until 2025-08-07); Murphy Canyon Acquisition Corp. (until 2023-09-21)

1Insiders filing

4Transactions

+$544Reported buys

−$544Reported sells

0Cluster events

Window in data: 2026-07-30 → 2026-08-28 · Data as of 2026-09-03

Insiders

Insider	Role	Txns	Reported value
Regan Andrew	Chief Executive Officer	4	$1k

Transaction history

Filing date	Trade date	Ticker	Insider	Type	Shares	Price	Value	Cluster
2026-09-02	2026-08-28	CDT	Regan Andrew Chief Executive Officer	J	5,436,830	—	—	—
2026-09-02	2026-08-28	CDT	Regan Andrew Chief Executive Officer	S	290	—	—	—
2026-09-02	2026-08-28	CDT	Regan Andrew Chief Executive Officer	X	5,436,830	$0.00	−$544	—
2026-09-02	2026-07-30	CDT	Regan Andrew Chief Executive Officer	J	5,436,830	$0.00	+$544	—

Known data limitations

Form 4 lag: insiders have 2 business days to file after a trade (weekends and holidays extend this), and this site re-ingests once daily — a transaction can appear here roughly three business days after it happened.
13F lag: quarterly 13F-HR holdings cover the prior quarter-end and are due 45 days after it — every institutional position shown here is at least 45 days old by construction, often more.
CUSIP→ticker gaps: 13F positions are reported by CUSIP; some holdings cannot be matched to a current ticker (delistings, corporate actions, thin metadata) and appear without one or are omitted from ticker-level views.
EDGAR timing variability: institutions file at different hours and days within their windows; amended filings (4/A, 13F-HR/A) can restate earlier periods, so historical aggregates may change between batches.

Insider Atlas is a descriptive research site, not investment advice — see the methodology for the full provenance chain.